Thursday, March 28, 2024
ADVT 
International

A look at COVID-19 vaccines already in use, or getting close

Darpan News Desk The Canadian Press, 29 Jan, 2021 11:00 PM
  • A look at COVID-19 vaccines already in use, or getting close

While a few have already hit the market, there are still dozens of coronavirus vaccines in development around the globe.

Some use tried-and-true technologies, other use novel approaches. The shots were all tested differently, and some were allowed to go into use even before they were rigorously tested. How well they work varies, with preliminary study results ranging from 50% effective to over 90%.

So far, regulators in different countries have allowed use of about a half dozen, mostly under emergency use provisions. A few more are getting close. The ones available now all require two doses, given weeks apart.

Among those furthest along:

Pfizer: Developed with BioNTech; authorized by the U.S., U.K, European Union, the World Health Organization and elsewhere.

Moderna: Developed with the U.S. National Institutes of Health; authorized by the U.S., U.K., European Union, the World Health Organization and elsewhere.

AstraZeneca: Developed with Oxford University; authorized by more than 40 countries, including Britain, India, Argentina, Mexico and the European Union.

Sputnik V: Developed by Russia's Gamaleya Research Institute; authorized in Russia and about 10 other countries.

Sinopharm: Authorized in China and several countries including Hungary, Serbia, and Morocco.

Sinovac: Authorized in China as well as Turkey, Brazil and Indonesia.

Bharat Biotech: Authorized in India.

Johnson & Johnson: In development; one dose; expected to seek U.S. Food and Drug Administration authorization soon.

Novavax: In development.

MORE International ARTICLES

U.S. House embarks on effort to push out Trump

U.S. House embarks on effort to push out Trump
Democratic lawmakers introduced a resolution today calling on Vice-President Mike Pence and the federal cabinet to remove Trump on the grounds he is unfit to lead.

U.S. House embarks on effort to push out Trump

Trump, after nod to loss, embraces his supporters

Trump, after nod to loss, embraces his supporters
Media reports suggest Vice-President Mike Pence won't support their other option: a constitutional rule that allows an unfit commander-in-chief to be removed from office.

Trump, after nod to loss, embraces his supporters

Uneasy calm settles on Capitol after day of chaos

Uneasy calm settles on Capitol after day of chaos
Overnight, just hours after Trump supporters forced their way into the building and terrorized lawmakers, Congress ultimately certified Joe Biden as U.S. president-elect.

Uneasy calm settles on Capitol after day of chaos

Trump supporters mass in D.C. as Biden era begins

Trump supporters mass in D.C. as Biden era begins
Several Republican lawmakers will formally object to president-elect Joe Biden's win, citing phoney allegations of election fraud — a futile exercise that will likely do little beyond delaying the inevitable.

Trump supporters mass in D.C. as Biden era begins

Fauci: US could soon give 1 million vaccinations a day

Fauci: US could soon give 1 million vaccinations a day
Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Fauci: US could soon give 1 million vaccinations a day

Trump call ratchets up political tension in U.S.

Trump call ratchets up political tension in U.S.
That demand is sure to reverberate Tuesday, when two run-off elections in Georgia will decide whether Democrats or Republicans control the Senate.

Trump call ratchets up political tension in U.S.